| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/28/2003 | EP0988048A4 Ligand/lytic peptide compositions and methods of use |
| 05/28/2003 | EP0981358B1 Dolastatin-15 derivatives in combination with taxanes |
| 05/28/2003 | EP0788509B1 Therapeutic peptide derivatives |
| 05/28/2003 | EP0449958B9 Meningococcal class 1 outer-membrane protein vaccine |
| 05/28/2003 | CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules |
| 05/28/2003 | CN1109557C Cetroretix lyophilisate and process for preparation thereof |
| 05/27/2003 | US6570070 Generating herbicide resistant plants; obtain plant, incubate with vector coding preferential enzymatic polypeptides, transform plant, propagate, monitor transgentic plants response to herbicides |
| 05/27/2003 | US6569998 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 05/27/2003 | US6569993 Process for the preparation of resin-bound cyclic peptides |
| 05/27/2003 | US6569834 Elucidation and synthesis of antineoplastic tetrapeptide w-aminoalkyl-amides |
| 05/27/2003 | US6569402 Vitronectin receptor antagonist pharmaceuticals |
| 05/27/2003 | CA2152963C A process for producing immunosuppressives and a novel microbial species to be employed therein |
| 05/22/2003 | WO2003042249A2 Peptide purification by means of metal ion affinity chromatography |
| 05/22/2003 | WO2003042247A2 Modified anti-tnf alpha antibody |
| 05/22/2003 | WO2003042239A1 Peptides inhibiting signaling by ras-like gtpases |
| 05/22/2003 | WO2003042163A1 N-methyl-homocystines, use thereof and method for the production thereof |
| 05/22/2003 | WO2003041729A1 Ptp1b inhibitors and ligands |
| 05/22/2003 | WO2003027255A3 Anti-fusion assay |
| 05/22/2003 | WO2003011115A3 Peptide-based multimeric targeted contrast agents |
| 05/22/2003 | US20030096953 Protein mixture for use in the detection of microbiocides |
| 05/22/2003 | US20030096948 Acylating a destryptophan compound to obtain an ornithin amino protected compound, removing the ornithine protecting group; antibiotic daptomycin stereoisomeric compounds |
| 05/22/2003 | US20030096760 Treating a bone resorption disease by administering a compound which forms a covalent bond or link to cys185 of the src SH2 domain |
| 05/22/2003 | US20030096758 Anticarcinogenic agents |
| 05/22/2003 | US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/22/2003 | US20030096745 A conjugated cecropins and magainins with one or more replaced peptides; bactericides, fungicides and anticarcinogenic agent; nontoxic |
| 05/22/2003 | US20030096738 Peptide vector |
| 05/22/2003 | US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 05/22/2003 | US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/22/2003 | US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling |
| 05/22/2003 | US20030095979 Xn-PeptideL-Xm, where X is Gly, Ala, Val, Leu, Ile, Pro, Phe, Tyr, Trp, Cys, Met, Glu or Asp; and PeptideL is a potentially immunogenic fragment; and a polycationic material; vaccines |
| 05/22/2003 | US20030095976 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 05/22/2003 | US20030095964 Process for producing humanized chimera antibody |
| 05/22/2003 | CA2467264A1 N-methyl-homocystines, use thereof and method for the production thereof |
| 05/22/2003 | CA2466592A1 Modified anti-tnf alpha antibody |
| 05/22/2003 | CA2461481A1 Ptp1b inhibitors and ligands |
| 05/21/2003 | EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/21/2003 | EP1311292A2 Vitronectin receptor antagonist pharmaceuticals |
| 05/21/2003 | EP1311281A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 05/21/2003 | EP1311280A2 Cell internalized peptide-drug conjugates |
| 05/21/2003 | EP1204675B1 Streptogramin derivatives, production thereof and compositions containing the same |
| 05/21/2003 | EP1189932B1 Novel echinocandin derivatives, method for preparing the same and use as antifungal agents |
| 05/21/2003 | EP0993303B1 Substances in order to achieve preference and create acceptance |
| 05/21/2003 | EP0866801B1 Cyclopeptolides |
| 05/21/2003 | CN1419565A Chimeric Prostate-homing peptides with pro-apoptotic activity |
| 05/21/2003 | CN1419563A Peptide derivative |
| 05/20/2003 | US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers |
| 05/20/2003 | US6566493 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
| 05/20/2003 | US6566491 Cyclopeptide derivatives |
| 05/20/2003 | US6566335 Administering a peptide derivative for mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood |
| 05/20/2003 | US6566334 Short amphipathic peptides with activity against bacteria and intracellular pathogens |
| 05/20/2003 | US6566327 Histogranin peptides and their analgesic use |
| 05/20/2003 | US6566129 Transformed cells useful for the control of pests |
| 05/20/2003 | US6566085 Synthetic peptides, antibodies directed against them, and the use thereof |
| 05/20/2003 | US6566077 Qualitative or quantitative analysis of immunoglobulin; generate solid support, incubate with immunoglobulin mixture, wash microtiter plate, detect complexed immunoglobulin |
| 05/20/2003 | US6565857 Coding human leukocyte antigen; anticancer, antitumor agent |
| 05/15/2003 | WO2003040693A2 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 05/15/2003 | WO2003040176A2 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 05/15/2003 | WO2003040175A1 Conjugate for treating by boron neutron capture (bnc) radiation-resistant tumours |
| 05/15/2003 | WO2003040174A2 Substituted amino ketone compounds |
| 05/15/2003 | WO2003040172A2 Methods and reagents for peptide-bir interaction screens |
| 05/15/2003 | WO2003040094A2 Methods for preparation of macrocyclic molecules macrocyclic molecules prepared thereby and substrates and solid supports for use therein |
| 05/15/2003 | WO2003039454A2 Beta-secretase inhibitors and methods of use |
| 05/15/2003 | WO2003039438A2 Pna-conjugates for treating chronic myeloid leukaemia (cml) |
| 05/15/2003 | WO2002092115A3 Method of preventing cell death using segments of neural thread proteins |
| 05/15/2003 | WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production |
| 05/15/2003 | WO2002026781A9 Ige receptor antagonists |
| 05/15/2003 | US20030092800 Sustained release; drug delivery |
| 05/15/2003 | US20030092631 IGF antagonist peptides |
| 05/15/2003 | US20030092630 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases |
| 05/15/2003 | US20030092613 Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides |
| 05/15/2003 | US20030092609 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |
| 05/15/2003 | US20030092067 Libraary of enzyme inhibitor or use in the treatment of cancer and parasitic disease |
| 05/15/2003 | US20030092065 Peptide for use in the treatment and prevention of allergies |
| 05/15/2003 | US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits |
| 05/15/2003 | US20030091565 Binding polypeptides and methods based thereon |
| 05/15/2003 | US20030091557 Methods and compositions for modulating ACE-2 activity |
| 05/15/2003 | CA2464736A1 Beta-secretase inhibitors and methods of use |
| 05/15/2003 | CA2463745A1 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 05/14/2003 | EP1310507A2 Novel peptide nucleic acids |
| 05/14/2003 | EP1309869A1 Designing and screening random libraries of compounds |
| 05/14/2003 | EP1309625A2 Therapeutic compounds for ovarian cancer |
| 05/14/2003 | EP1309622A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 05/14/2003 | EP1309612A2 Pseudo-metalloproteins, corresponding preparation and use as biosensors |
| 05/14/2003 | EP1309611A1 Anti-heparin peptides |
| 05/14/2003 | EP1309610A2 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 05/14/2003 | EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 05/14/2003 | EP1309355A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2003 | EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 05/14/2003 | EP1309336A1 Derivatives of laspartomycin and preparation and use thereof |
| 05/14/2003 | EP1140987B1 Peptides for inhibiting hpv e6 proteins |
| 05/14/2003 | EP0772633B1 Complexes for use in the diagnosis of vascular diseases |
| 05/14/2003 | EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine |
| 05/14/2003 | CN1418222A Novel peptide and screening method by using the same |
| 05/14/2003 | CN1418112A Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 05/14/2003 | CN1418106A 疫苗 Vaccine |
| 05/13/2003 | US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/13/2003 | US6562786 Compounds and methods for modulating apoptosis |
| 05/13/2003 | US6562632 Reactive dye for use as diagnostic tool in the analysis of biological systems |
| 05/13/2003 | US6562590 Controlling biological pests; generate genetically engineered microorganism, expose to insect pests, monitor effect on insect propagation |
| 05/13/2003 | US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |